Study of PD1 and PDL1 Expression in Cutaneous T-Cell Lymphomas

被引:0
|
作者
Gorenkova, Lilya [1 ]
Mangasarova, Yana [1 ]
Shcherstnev, Andrey [1 ]
Kovrigina, Alla [1 ]
Julhakyan, Hunan [1 ]
Zvonkov, Evgeny [1 ]
机构
[1] Natl Med Res Ctr Hematol, Moscow, Russia
来源
关键词
TCL; PD-1; PDL-1; cutaneous T-cell lymphoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TCL-177
引用
收藏
页码:S466 / S466
页数:1
相关论文
共 50 条
  • [1] PD1 and PDL1 Expression in Richter Transformation
    Griffin, Brannan
    Chen, Yi-Hua
    Behdad, Amir
    Ma, Shuo
    Kelemen, Katalin
    Chen, Qing
    MODERN PATHOLOGY, 2018, 31 : 518 - 519
  • [2] PD1 and PDL1 Expression in Richter Transformation
    Griffin, Brannan
    Chen, Yi-Hua
    Behdad, Amir
    Ma, Shuo
    Kelemen, Katalin
    Chen, Qing
    LABORATORY INVESTIGATION, 2018, 98 : 518 - 519
  • [3] PD1 and PDL1 Expression in Midgut Neuroendocrine Tumors
    Cives, M.
    Strosberg, J.
    Coppola, D.
    NEUROENDOCRINOLOGY, 2016, 103 : 36 - 37
  • [4] Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia
    Yang, Kun
    Xu, Jing
    Liu, Qinghang
    Li, Jing
    Xi, Yanfeng
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (02) : 265 - 271
  • [5] PD1/PDL1 Biomarker Strategies
    Brambilla, Elisabeth
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S126 - S127
  • [6] Resistance to PD1/PDL1 checkpoint inhibition
    O'Donnell, Jake S.
    Long, Georgina V.
    Scolyer, Richard A.
    Teng, Michele W. L.
    Smyth, Mark J.
    CANCER TREATMENT REVIEWS, 2017, 52 : 71 - 81
  • [7] TREATMENT TARGETING PD1/PDL1 AND TOXICITY
    Brahmer, Julie
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S53 - S54
  • [8] Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
    Ameli, Fereshteh
    Shajareh, Elham
    Mokhtari, Maral
    Kosari, Farid
    BMC CANCER, 2022, 22 (01)
  • [10] Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
    Fereshteh Ameli
    Elham Shajareh
    Maral Mokhtari
    Farid Kosari
    BMC Cancer, 22